INS and cancer: Fenretinide is known to have a breadth of effects on cell homeostasis, interfering with retinol binding and transport, cell survival, inducing apoptosis in cancer and RPE cells, and improving insulin sensitivity and glucose homeostasis in vitro and in vivo [22,23,34,36,49].